Similar articles

• Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.

  Kirpekar M, Kirpekar SM, Prat JC. Kirpekar M, et al. Br J Pharmacol. 1978 Jan;62(1):75-8. doi: 10.1111/j.1476-5381.1978.tb07008.x. Br J Pharmacol. 1978. PMID: 620099 Free PMC article.
• Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.

  Thoenen H, Huerlimann A, Haefely W. Thoenen H, et al. J Pharmacol Exp Ther. 1966 Feb;151(2):189-95. J Pharmacol Exp Ther. 1966. PMID: 5932597 No abstract available.
• Effect of tetraethylammonium on noradrenaline release from cat spleen treated with tetrodotoxin.

  Kirpekar SM, Prat JC. Kirpekar SM, et al. Nature. 1978 Dec 7;276(5688):623-4. doi: 10.1038/276623a0. Nature. 1978. PMID: 723946 No abstract available.
• Reversal of bretylium blockade of adrenergic nerve terminals by tetraethylammonium.

  Kirpekar M, Kirpekar SM, Prat JC. Kirpekar M, et al. Biochem Pharmacol. 1978 May 15;27(10):1512-3. doi: 10.1016/0006-2952(78)90111-9. Biochem Pharmacol. 1978. PMID: 697893 No abstract available.
• Tetraethylammonium-induced contractions of frog's skeletal muscle. II. Effects on intramuscular nerve endings.

  Beaulieu G, Frank GB, Inoue F. Beaulieu G, et al. Can J Physiol Pharmacol. 1967 Sep;45(5):833-44. doi: 10.1139/y67-098. Can J Physiol Pharmacol. 1967. PMID: 6049611 No abstract available.